s
Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor
06-03-2024, 10:32
NAPERVILLE, Ill., March 5, 2024 /PRNewswire/ — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at the intersection of digital health and medtech, presented 6-month results from its PROACTIVE-HF pivotal trial. PROACTIVE-HF evaluated the company’s investigational Cordella Pulmonary Artery (PA) Sensor in New York Heart Association (NYHA) class III […] L'articolo Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor proviene da La Ragione.
CONTINUA A LEGGERE
8
0
0
Guarda anche
Libero Quotidiano
![Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data](/img/static/get.php?image=https://www.liberoquotidiano.it/assets/images/placeholder_libero_gallery.png)
Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data
La Ragione
19:43
Keys si fa male e si ritira, Paolini ai quarti di Wimbledon
La Ragione
19:34
Domina, poi soffre, ma vince in tre set: Sinner ai quarti
La Ragione
19:06